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Semicarbazide-sensitive amino oxidase Inhibitors
Semicarbazide-sensitive amine oxidases (SSAOs) are a widespread group of enzymes found in
plants and animals, which possess a copper atom and an oxidised tyrosine residue
(topaquinone) in their active site. While they appear to be involved in the oxidative
deamination of endogenous amines, their precise function has yet to be elucidated. In humans,
SSAOs have been implicated in the physiopathology of diabetes. Elevated levels of SSAO
have been reported in diabetics and it is believed that vascular damage may be due to the
toxicity of formaldehyde and hydrogen peroxide formed by the action of SSAO on
endogenous methylamine. Drugs that inhibit SSAOs may thus prove useful as prophylactics
preventing long-term retinal damage associated with diabetes mellitus (Combinatorial synthesis
of SSAO inhibitors using Sonogashira coupling: SAR of aryl propargylic amines, C. Conn et.
al., Bioorg. Med. Chem. Lett., 11, (2001), 2565-2568).
A small library of 20 single aryl propargyl amines was synthesised in solution. Evaluation of
this library testing the ability of compounds synthesised to inhibit bovine plasma SSAO gave
several potent compounds. One of the most potent isolated was (i) which possessed a Ki of
2.9 µM. The SAR obtained from studying compounds contained within this library suggests
that binding to the active site occurs by co-ordination of the amine to the proximal copper (II)
and formation of a π-complex between topaquinone and the electron-rich aryl group of the
inhibitor. Further putative inhibitors are currently being synthesised; their design based on the
SAR obtained from the small library discussed above, in order to test this hypothesis.
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Tyrosine and dual-specificity protein phosphatase inhibitors
Tyrosine phosphorylation of proteins is a fundamental mechanism of intracellular signal
transduction involved in important cellular events such as cell growth and differentiation. The
phosphorylation states of proteins are strictly controlled by various protein tyrosine kinases
(PTKs) and protein tyrosine phosphatases (PTPs). PTPs represent a diverse family of enzymes
that exist as integral membrane and nonreceptor forms. Disorders of PTPs are likely to be
related to several serious diseases such as cancers, autoimmune diseases and diabetes, and the
characterisation of PTPs are expected to be useful tools for clarifying the biological functions
of the PTPs as well as candidates for novel therapeutics.
Recently among the PTPs a group of enzymes that dephosphorylate both phosphotyrosine and
phosphoserine/threonine have attracted attention. In particular, CDC25 phosphatases
(CDC25A, -B, and -C) are considered important members of a family of dual-specificity
phosphatases (DSPs) known to be key enzymes in cell-cycle progression. CDC25
dephosphorylates and activates cyclin-dependent kinases. In order to find a selective inhibitor
of CDC25 and also other biological important PTPs/DSPs, a focussed library was synthesised
which utilised the structural features of PTPs/DSPs for its design (Synthesis of a tetronic acid
library focused on inhibition of tyrosine and dual-specificity protein phosphatases and its
evaluation regarding VHR and CDC25 inhibition, M. Sodeoka et. al., J. Med. Chem., 44,
(2001), 3216-3222).
A small library of 32 single compounds was synthesised in solution. Screening assays were
performed against a recombinant vaccinia VH-1 related phosphatase (VHR) protein, using p-
nitrophenyl phosphate as substrate to determine the compounds ability to act as VHR
inhibitors. VHR is itself is a DSP. VHR has been found to dephosphorylate and inactivate
members of the MAPK family. Additionally, compounds were tested for their ability to inhibit
a recombinant CDC25B protein, using 3-O-methylfluorescein phosphatate as substrate. One of
the most active compounds obtained was (ii) which gave an IC50 of 400 nM against CDC25B,
and possessed 30-fold selectivity over the closely related DSP, VHR.  This work indicates that
synthesis of the tetronic acid library has been useful in the search for a PTP/DSP-selective
inhibitor. Expansion of this library and research to find more powerful and highly selective
inhibitors of CDC25, and several other therapeutically important PTPs/DSPs, is worthwhile.
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